Q1 2024 EPS Estimates for bluebird bio, Inc. (NASDAQ:BLUE) Reduced by Analyst

bluebird bio, Inc. (NASDAQ:BLUE – Free Report) – Analysts at Leerink Partnrs decreased their Q1 2024 earnings per share estimates for shares of bluebird bio in a research report issued on Tuesday, March 26th. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will post earnings per share of ($0.29) for the quarter, […]

Leave a Reply

Your email address will not be published.

Previous post Brokers Offer Predictions for Citizens Financial Group, Inc.’s Q1 2024 Earnings (NYSE:CFG)
Next post Lavoro (LVRO) versus Its Rivals Head-To-Head Comparison